NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.45%160.070.0%$1484.90m
NVAXNovavax, Inc. -6.32%84.6578.2%$581.13m
AMGNAmgen, Inc. -0.52%227.721.4%$512.75m
BIIBBiogen, Inc. -2.39%220.521.8%$496.77m
GILDGilead Sciences, Inc. 1.03%68.511.0%$492.03m
BNTXBioNTech SE -5.77%147.500.0%$413.51m
REGNRegeneron Pharmaceuticals, Inc. 1.14%621.402.7%$402.73m
ILMNIllumina, Inc. -3.81%365.943.3%$378.85m
VRTXVertex Pharmaceuticals, Inc. -0.23%228.081.9%$340.95m
SNSSSunesis Pharmaceuticals, Inc. -3.99%2.650.7%$185.24m
EXASEXACT Sciences Corp. -2.63%74.0317.9%$168.66m
ARNAArena Pharmaceuticals, Inc. -0.58%90.4813.7%$131.37m
INCYIncyte Corp. 0.04%74.792.4%$130.18m
ALNYAlnylam Pharmaceuticals, Inc. -1.37%136.418.2%$125.00m
BMRNBioMarin Pharmaceutical, Inc. 0.24%84.654.2%$103.18m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.